Unicycive Therapeutics, Inc..
UNCY.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Unicycive Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for kidney disease. Their primary focus is on developing Renazorb, a phosphate binding agent, for the treatment of hyperphosphatemia in patients with chronic kidney disease (CKD), in...Show More
Better Health for All
0
No evidence available to assess Unicycive Therapeutics, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
Unicycive Therapeutics, Inc. is a biopharmaceutical company focused on research, development, and commercialization of therapies for kidney disease. The company does not offer lending, deposit services, consumer credit products, or other financial services. Therefore, all KPIs related to financial services, such as underserved client share, pricing fairness, exploitative fee exposure, inclusion initiatives, data accessibility, fair lending compliance, wealth building outcomes, profit reinvestment in community finance, financial literacy initiatives, debt burden ratio, geographic inclusion, and product simplicity, are not applicable to its core business model.
Fair Pay & Worker Respect
0
No substantiated labor-law or human-rights violations by Unicycive Therapeutics, Inc. are reported in the provided articles. A securities class action lawsuit and FDA-identified deficiencies at a third-party manufacturing vendor were noted, but these do not pertain to the company's own labor practices or human rights record.
1
Fair Trade & Ethical Sourcing
0
Unicycive Therapeutics, Inc. is a biopharmaceutical company focused on research, development, and commercialization, and does not manufacture pharmaceuticals. Due to this operational model, the company does not procure or trade physical commodities, nor does it have a supplier base or supply chain tiers that would typically require fair-trade certifications, sourcing audits, or involve high-risk materials. Therefore, all KPIs related to fair trade and ethical sourcing are not applicable.
Honest & Fair Business
0
No evidence available to assess Unicycive Therapeutics, Inc. on Honest & Fair Business.
Kind to Animals
0
The provided articles are primarily financial documents (Form S-3 filings) and explicitly state they do not contain information related to animal welfare or ethical sourcing.
1
Several linked articles resulted in 404 errors, providing no content.
2
Consequently, no specific, concrete data points, policies, or certifications pertaining to any of the 'Kind to Animals' KPIs were found across the evidence.
3
Therefore, all KPIs are omitted due to a complete lack of relevant information.
No War, No Weapons
0
The provided articles do not contain any specific, concrete data points or information relevant to Unicycive Therapeutics, Inc.'s involvement with arms or defense contracts, dual-use technologies, sales to embargoed regimes, peacebuilding investments, or any other metrics related to the 'No War, No Weapons' ethical value.
1
Therefore, no KPIs can be scored based on the evidence provided.
Planet-Friendly Business
0
No sustainability data or specific planet-friendly business metrics are available for UNCY.US in the provided articles.
1
There is no quantitative data, information on regulatory actions, violations, fines, compliance issues, certifications, awards, or recognitions related to environmental performance.
2
Respect for Cultures & Communities
0
The provided articles do not contain any specific, concrete data points or evidence related to Unicycive Therapeutics, Inc.'s performance on any of the Key Performance Indicators for 'Respect for Cultures & Communities'. The articles focus on employment agreements
1
, Nasdaq compliance
2
, career opportunities
3
, and research and development in kidney health
4
, none of which provide information on community engagement, cultural impact assessments, local employment, or other relevant metrics.
Safe & Smart Tech
-50
The company has no documented incidents of unauthorized data use.
1
Its privacy policy, last updated in November 2025, states that users can opt out of marketing emails, Nevada residents can opt out of the future sale of their information, and users can control cookies via browser settings and a preference center.
2
However, the company collects extensive personal data, including contact, job applicant, and site usage information, combines online and offline data, shares information with affiliates and vendors, and explicitly states it does not currently respond to 'Do Not Track' signals.
3
The company engages third-party services for security control evaluations, including penetration testing and independent audits, but the scope and frequency of this testing are not specified.
4
The company is subject to U.S. and foreign export/import controls, sanctions, anti-corruption, and anti-money laundering laws.
5
It must comply with FDA requirements for safeguarding patient information and SEC cybersecurity incident reporting.
6
The company acknowledges that HIPAA, as amended by HITECH, imposes requirements and increased penalties for privacy and security violations, and state laws governing health information privacy and security often differ significantly, complicating compliance efforts.
7
The company states it may need to expend significant capital to ensure ongoing compliance.
8
Zero Waste & Sustainable Products
0
No sustainability data is available for UNCY.US, therefore no specific evidence could be found to assess the company against any of the Zero Waste & Sustainable Products KPIs.
1